Equity Overview
Price & Market Data
Price: $0.108
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $1,010,091
Volume: 0
Performance Metrics
1 Week: -2.43%
1 Month: -6.44%
3 Months: -93.59%
6 Months: -93.59%
1 Year: -97.11%
YTD: -97.31%
Details
Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.